Springfield, VA, United States of America

Sie-Mun Lo


 

Average Co-Inventor Count = 9.8

ph-index = 2

Forward Citations = 28(Granted Patents)


Location History:

  • Revere, MA (US) (2015)
  • Springfield, VA (US) (2015 - 2016)

Company Filing History:


Years Active: 2015-2016

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Inventor Sie-Mun Lo in Cancer Treatment

Introduction: Sie-Mun Lo, an inventive and dedicated researcher located in Springfield, VA, has made significant contributions to the field of pharmaceuticals, particularly in developing compounds that serve as ERK inhibitors. With a total of four patents to his name, his work is paving the way for advancements in cancer treatment.

Latest Patents: Among Sie-Mun Lo's recent innovations are two notable patents focused on indazole derivatives and heterocyclic compounds. The first invention, titled "Indazole derivatives useful as ERK inhibitors," presents a compound described by a specific formula, which includes a pharmaceutically acceptable salt, solvate, or ester. These compounds are aimed at inhibiting ERK, an important pathway in cancer cell proliferation. The second patent, "Heterocyclic compounds as ERK inhibitors," similarly outlines a compound that serves as an ERK inhibitor, providing promising methods for treating cancer through innovative pharmaceutical compositions.

Career Highlights: Sie-Mun Lo’s career is marked by his association with Merck Sharp & Dohme Corporation, a leading global healthcare company. His research and developments in ERK inhibitors reflect his commitment to finding effective solutions for complex medical challenges. Lo's extensive knowledge and expertise in pharmaceutical sciences have established him as a valuable asset in the field.

Collaborations: Throughout his career, Sie-Mun Lo has collaborated with notable colleagues, including Gerald Wayne Shipps, Jr. and Liang Zhu. These collaborations have facilitated the sharing of ideas and knowledge, ultimately enhancing the research outcomes and contributing to innovative discoveries in cancer treatment.

Conclusion: Sie-Mun Lo's work exemplifies the spirit of innovation within the pharmaceutical industry. His patents not only signify technical advancements but also underscore his dedication to combating cancer through scientific research. As he continues to develop new compounds, the potential for improved treatment options grows, promising hope to many affected by cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…